Atalan Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Atalan Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-110,000	Closed	-$44.6M	–	11
2025 Q2	$44.6M	Hold	110,000	–	–	3.43%	11
2025 Q1	$54.7M	Hold	110,000	–	–	5.2%	9
2024 Q4	$57.2M	Sell	110,000 -69,000	-39%	-$37.9M	5.69%	9
2024 Q3	$111M	Sell	179,000 -10,000	-5%	-$5.92M	9.52%	7
2024 Q2	$105M	Sell	189,000 -14,000	-7%	-$8.02M	9.74%	6
2024 Q1	$118M	Hold	203,000	–	–	9.75%	6
2023 Q4	$108M	Buy	203,000 +33,000	+19%	+$16M	9.49%	6
2023 Q3	$86M	Buy	170,000 +95,000	+127%	+$50.6M	8.06%	7
2023 Q2	$39.1M	Buy	+75,000	New	+$40.5M	3.07%	9

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Atalan Capital Partners's TMO Position: Q3 2025 in Review

Atalan Capital Partners sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 110,000 shares — an estimated $44.6M sold.

Atalan Capital Partners first reported a position in TMO in Q2 2023 and held it in 9 quarters. The position peaked at $118M in Q1 2024. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

Atalan Capital Partners reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
Atalan Capital Partners sold 110,000 Thermo Fisher Scientific shares in Q3 2025, an estimated $44.6M.
Atalan Capital Partners first reported a position in Thermo Fisher Scientific in Q2 2023 and held it in 9 quarters.
Atalan Capital Partners's Thermo Fisher Scientific position peaked at $118M in Q1 2024.
2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Atalan Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.